These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27294805)

  • 1. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
    Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
    Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
    Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
    Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
    PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial membrane protein-2 (EMP2) and experimental proliferative vitreoretinopathy (PVR).
    Telander DG; Morales SA; Mareninov S; Forward K; Gordon LK
    Curr Eye Res; 2011 Jun; 36(6):546-52. PubMed ID: 21591864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
    Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
    Commun Biol; 2019; 2():162. PubMed ID: 31069271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
    Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
    Nagasaka Y; Kaneko H; Ye F; Kachi S; Asami T; Kato S; Takayama K; Hwang SJ; Kataoka K; Shimizu H; Iwase T; Funahashi Y; Higuchi A; Senga T; Terasaki H
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):221-229. PubMed ID: 28114583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
    Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
    Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
    Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic evidence that ABCA4 is vital for traumatic proliferative vitreoretinopathy formation and development.
    Wang M; Li Q; Dong H
    Exp Eye Res; 2019 Apr; 181():232-239. PubMed ID: 30738069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
    He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
    Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.